ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
ejjwj
|
1.4K |
707K |
11 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
1.4K
|
707K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Announces A$600 Million Convertible Bonds Offering
|
|
ejjwj
|
41 |
14K |
12 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
41
|
14K
|
12
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
ejjwj
|
1.4K |
707K |
15 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
1.4K
|
707K
|
15
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ejjwj
|
556 |
222K |
13 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
556
|
222K
|
13
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
ejjwj
|
1.4K |
707K |
4 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
1.4K
|
707K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
ejjwj
|
1.4K |
707K |
9 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
1.4K
|
707K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ejjwj
|
922 |
323K |
9 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
922
|
323K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Elects to Withdraw from Proposed U.S. Listing
|
|
ejjwj
|
116 |
45K |
15 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
116
|
45K
|
15
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
ejjwj
|
190 |
65K |
4 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
190
|
65K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Change in substantial holding
|
|
ejjwj
|
14 |
7.2K |
2 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
14
|
7.2K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Appendix 4D and Half year report
|
|
ejjwj
|
10 |
3.8K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
10
|
3.8K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
4 |
2.1K |
3 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
4
|
2.1K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
4 |
2.1K |
2 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
4
|
2.1K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
ejjwj
|
404 |
148K |
4 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
404
|
148K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Appointment of Non-executive Director
|
|
ejjwj
|
4 |
966 |
1 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
4
|
966
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Proposed Capital Return to Shareholders of $14.0 Million
|
|
ejjwj
|
82 |
26K |
0 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
82
|
26K
|
0
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
ejjwj
|
197 |
81K |
2 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
197
|
81K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Becoming a substantial holder
|
|
ejjwj
|
17 |
6.1K |
1 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
17
|
6.1K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Change of Director's Interest Notice
|
|
ejjwj
|
8 |
2.3K |
4 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
8
|
2.3K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex to close IIH Evolve Phase III Clinical Trial
|
|
ejjwj
|
41 |
10K |
2 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
41
|
10K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex to close IIH Evolve Phase III Clinical Trial
|
|
ejjwj
|
41 |
10K |
1 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
41
|
10K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex to close IIH Evolve Phase III Clinical Trial
|
|
ejjwj
|
41 |
10K |
2 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
41
|
10K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Competition
|
|
ejjwj
|
254 |
117K |
3 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
254
|
117K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
ejjwj
|
1.5K |
602K |
4 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
1.5K
|
602K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
ejjwj
|
1.5K |
602K |
3 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
1.5K
|
602K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Acquires Optimal Tracers
|
|
ejjwj
|
64 |
23K |
7 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
64
|
23K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Director Resignations and Appointment of Non-Executive Chair
|
|
ejjwj
|
77 |
21K |
2 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
77
|
21K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
ejjwj
|
219 |
47K |
6 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
219
|
47K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
ejjwj
|
219 |
47K |
1 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
219
|
47K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Director Resignations and Appointment of Non-Executive Chair
|
|
ejjwj
|
77 |
21K |
2 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
77
|
21K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Director Resignations and Appointment of Non-Executive Chair
|
|
ejjwj
|
77 |
21K |
3 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
77
|
21K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Director Resignations and Appointment of Non-Executive Chair
|
|
ejjwj
|
77 |
21K |
0 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
77
|
21K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
ejjwj
|
224 |
56K |
1 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
224
|
56K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
ejjwj
|
224 |
56K |
5 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
224
|
56K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
ejjwj
|
224 |
56K |
0 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
224
|
56K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
ejjwj
|
224 |
56K |
2 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
224
|
56K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
ejjwj
|
224 |
56K |
1 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
224
|
56K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
ejjwj
|
224 |
56K |
3 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
224
|
56K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
ejjwj
|
224 |
56K |
5 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
224
|
56K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
ejjwj
|
224 |
56K |
8 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
224
|
56K
|
8
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
ejjwj
|
224 |
56K |
6 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
224
|
56K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Ann: First Patient Randomised in IIH EVOLVE Phase III Trial
|
|
ejjwj
|
55 |
10K |
6 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
55
|
10K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted European Orphan Drug Designation for TBI
|
|
ejjwj
|
74 |
17K |
8 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
74
|
17K
|
8
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
ejjwj
|
40 |
9.7K |
4 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
40
|
9.7K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
ejjwj
|
523 |
98K |
1 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
523
|
98K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
ejjwj
|
523 |
98K |
4 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
523
|
98K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
ejjwj
|
523 |
98K |
3 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
523
|
98K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
ejjwj
|
219 |
47K |
4 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
219
|
47K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
ejjwj
|
219 |
47K |
2 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
219
|
47K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
ejjwj
|
1.5K |
602K |
4 |
04/06/23 |
04/06/23 |
ASX - By Stock
|
1.5K
|
602K
|
4
|
|